New York AG: Teva USA’s parent company shouldn’t be allowed to escape opioid liability
Without the parent company, there's concern Teva won't be able to pay billions in reward to NY state.
Humana, Centene file antitrust suit against Gilead for HIV drug agreements
The insurers referred to deals Gilead struck with Janssen, Bristol Myers Squibb to prevent the generic version of its retroviral medications from being used as part of combination treatments. They also allege the company struck a deal with Teva to delay the release of its generic drug.
presented by
The 5 Best Software to Buy for Managing a Spa Franchise
Choosing the right software translates directly into better client management, operational efficiency and growth for your spa franchise. Discover which tool is best for your business.
Four big pharma companies team up in AI initiative focused on drug R&D
A new startup initiative in Israel aims to create and invest in startups that use artificial intelligence to address challenges in drug discovery and development. Called AION Labs, this innovation lab stems from an economic development effort from the Israeli government and will have contributions from AstraZeneca, Merck, Pfizer and Teva Pharmaceutical.
Past the pill and product: What do VCs want?
During a panel at MedCity INVEST, four experts addressed what VCs and potential acquirers are looking for in emerging companies.
Teva CEO stands down during troubled times
Teva Pharmaceuticals' CEO Erez Vigodman stepped down on Monday — "effective immediately" — after a tumultuous few years at the helm.